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Background
Macrophages play a key role in iron homeostasis. In peripheral tissues, they are known to
polarize into classically activated (or M1) macrophages and alternatively activated (or M2)
macrophages. Little is known on whether the polarization program influences the ability of
macrophages to store or recycle iron and the molecular machinery involved in the processes.
Design and Methods
Inflammatory/M1 and alternatively activated/M2 macrophages were propagated in vitro from
mouse bone-marrow precursors and polarized in the presence of recombinant interferon-γ or
interleukin-4. We characterized and compared their ability to handle radioactive iron, the char-
acteristics of the intracellular iron pools and the expression of molecules involved in internal-
ization, storage and export of the metal. Moreover we verified the influence of iron on the rel-
ative ability of polarized macrophages to activate antigen-specific T cells. 
Results
M1 macrophages have low iron regulatory protein 1 and 2 binding activity, express high levels
of ferritin H, low levels of transferrin receptor 1 and internalize – albeit with low efficiency -
iron only when its extracellular concentration is high. In contrast, M2 macrophages have high
iron regulatory protein binding activity, express low levels of ferritin H and high levels of trans-
ferrin receptor 1. M2 macrophages have a larger intracellular labile iron pool, effectively take
up and spontaneously release iron at low concentrations and have limited storage ability. Iron
export correlates with the expression of ferroportin, which is higher in M2 macrophages. M1
and M2 cells activate antigen-specific, MHC class II-restricted T cells. In the absence of the
metal, only M1 macrophages are effective. 
Conclusions
Cytokines that drive macrophage polarization ultimately control iron handling, leading to the
differentiation of macrophages into a subset which has a relatively sealed intracellular iron con-
tent (M1) or into a subset endowed with the ability to recycle the metal (M2).
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Introduction
Macrophages are heterogeneous populations that polar-
ize, depending on microenvironmental cues, into classically
activated (or M1) and alternatively activated (or M2)
macrophages. The two populations are functionally differ-
ent: M1 cells exhibit potent anti-microbial properties and
promote Th1 responses while M2 cells support Th2-associ-
ated effector functions.1
Macrophages are widely distributed in peripheral tissues
where they play an indispensable role in the defense
against pathogens. This is at least partially achieved
through the control of intracellular iron availability, which
limits pathogen growth.2 Macrophages are also important
in the maintenance of tissue homeostasis and in the resolu-
tion of inflammation. These functions are achieved through
the macrophages ability to release trophic factors1,3 and
their clearance and iron recycling capacities, which are
important for tissue remodeling and repair. 
Iron homeostasis requires the finely tuned expression of
molecules involved in iron uptake, storage, export and
heme degradation.4,5 The transcriptional and post-transcrip-
tional control of many of the genes responsible for these
functions depends on inflammatory cytokines, free radi-
cals, and on the ability of iron regulatory proteins 1 and 2
(IRP1, IRP2) to bind to iron responsive elements (IRE) on
target mRNA.6
In this study, we verified how the functional polarization
of primary murine macrophages towards an inflammato-
ry/M1 or an alternative/M2 phenotype controls the expres-
sion of iron related genes and their ability to manage iron
in conditions of iron overload or deficiency.
Design and Methods
Materials 
Hemin, ferric ammonium citrate (FAC) and ascorbic acid,
were purchased from Sigma (St. Louis, MI, USA).
Deferroxamine mesylate (DFO) was obtained from
Biofutura Pharma (Milan, Italy). Recombinant murine (rm)
macrophage colony-stimulating factor (M-CSF) and rm
interleukin-4 (IL4) were from R&D Systems (Minneapolis,
MN, USA); rm-interferon-gamma (IFNγ) was purchased
from PeproTech (Rocky Hill, NJ, USA). All labeled mono-
clonal antibodies were from BD Biosciences Pharmigen
(San Jose, CA, USA).
Macrophages 
Bone marrow precursors from C57BL/6 female mice
were isolated and propagated for 7 days in α-MEM
(GIBCO, Invitrogen, Carlsbad, CA, USA) containing 10%
fetal bovine serum (Lonza, Basel, Switzerland) in the pres-
ence of rm-M-CSF (100 ng/mL) to generate macrophages as
described elsewhere.7 Cells were cultured for 2 additional
days in the presence of rm-IFNγ (50 ng/mL) to generate M1
cells and for 4 additional days with rm-IL4 (10 ng/mL) and
rm-M-CSF (10 ng/mL) to generate M2 cells. Macrophage
polarization was verified by flow cytometry after staining
with fluorochrome-conjugated antibodies.8 Briefly, 100,000
macrophages were incubated with fluorescent-specific
antibodies or isotype control antibodies at 4°C for 20 min
(final concentration 5 μg/mL) in phosphate-buffered saline
containing 10% fetal bovine serum. APC-conjugated anti-
CD11b antibodies were used to identify macrophages and
FITC-conjugated anti-HMC class I and class II, CD86 and
CD163 antibodies to discriminate between M1 (class I,
class II and CD86 high, CD163 intermediate) and M2
macrophages (class I and class II intermediate, CD86 low,
CD163 high). Macrophage polarization was also verified
by evaluating the concentration of selected soluble mole-
cules in the culture supernatant by enzyme-linked
immunosorbent assay (ELISA) (DuoSet Kit, R&D System,
Minneapolis, MN, USA). The molecules assayed were:
tumor necrosis factor-alpha (TNFα), soluble TNFα recep-
tors I and II (sTNFR-I and sTNFR-II), CXCL12, IL4, IL10,
IL6 and IL13. Transferrin receptor (TfR) expression was
assessed using a FITC-conjugated anti-CD71 antibody (BD
Biosciences) as above. Labeled cells were washed and ana-
lyzed using a FACS-Calibur flow cytometer and FlowJo
software (Tree Star Inc., Ashland, OR, USA). Results are
expressed as relative fluorescence intensity (RFI), calculated
by dividing the mean fluorescence intensity obtained in the
experimental sample by the one obtained with the isotype-
matched control antibody.
When indicated, macrophages were incubated over-night
in complete medium in the presence or in the absence of
hemin (100 μM), FAC (150 μM) plus ascorbic acid (150 μM)
or DFO (150 μM). 
Gene-expression profiling and data analysis 
Gene expression profiling analysis was carried out as
described with minor modifications.9 Total cellular RNA
was extracted from M1 and M2 polarized macrophages
using the RNeasy midi kit, following the manufacturer’s
recommendations. All analyses were performed in quadru-
plicate. Disposable RNA chips (Agilent RNA 6000 Nano
LabChip kit) were used to determine the concentration and
purity/integrity of RNA samples using an Agilent 2100 bio-
analyzer. cDNA synthesis, biotin-labeled target synthesis,
HG-U133 plus 2.0 GeneChip (Affymetrix, Santa Clara, CA,
USA) array hybridization, staining and scanning were per-
formed according to the standard protocol supplied by
Affymetrix. The GeneChip mouse expression set 430 2.0,
which provides comprehensive coverage of the mouse
transcriptome, was used. Raw data were acquired using the
Affymetrix® GeneChip® Command Console® (AGCC)
software. Data processing and appropriate statistical analy-
sis (ANOVA, time course analysis, etc.) and all data quality
controls were performed using R (Bioconductor) and
Partek® Genomic Suite. The functional analyses were gen-
erated through the use of Ingenuity Pathways Analysis
(Ingenuity® Systems, www.ingenuity.com). 
RNA (1 μg) was used for qualitative polymerase chain
reaction (qPCR) analysis for first-strand synthesis of cDNA
with the High Capacity cDNA Reverse Transcription kit
(Applied Biosystems, Carlsbad, CA, USA) according to the
manufacturer's instructions. qPCR was done using SYBR-
green PCR Master Mix (Applied Biosystems). Each cDNA
sample was amplified in triplicate on a real-time PCR sys-
tem (7900HT Fast Real-Time PCR System, Applied
Biosystems). The level of each RNA was normalized to the
corresponding level of β-actin mRNA. The following
primers were used: TfR1 forward: 5'-TGATTGTTA-
GAGCAGGGGAAA-3', TfR1 reverse: 5'-ATGACTGA-
GATGGCGGAAAC-3', β-actin forward: 5'-TGCTGTCC-
CTGTATGCCTCT-3', β-actin reverse: 5'-GATGTCACG-
CACGATTTCC-3', HO-1 forward: 5'-GACACCTGAG-
GTCAAGCACAG-3', HO-1 reverse: 5'-CCACTGC-
CACTGTTGCCAAC-3', FtH forward: 5'-GTCAGCT-
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TAGCTCTCATCAC-3', FtH reverse: 5'-ACGTCTATCT-
GTCTATGTCTTG-3', ferroportin forward 5’- CCAGT-
GTCCCCAACTACCAA-3’, ferroportin reverse 5’-
GTCACCGTCAAAT CAAAGGA-3’. 
RNA-protein gel retardation assay 
Cells (2¥106) were homogenized in Hepes 10 mM, pH
7.6, MgCl2 3 mM, KCl 40 mM, glycerol 5%, Nonidet P40
0.2% (Sigma), protease inhibitor mixture (Sigma) and
dithiothreitol (DTT) 1 mM and centrifuged at 16,000 x g for
5 min at 4°C. The probe for the band-shift assay was tran-
scribed from the linearized pSPT-fer plasmid containing the
IRE of the human ferritin heavy (FtH) chain10 using T7 RNA
polymerase in the presence of [32P]UTP in a commercially
available kit (Promega Corp., Milan, Italy). Equal amounts
of protein (2 μg, as determined using the BCA protein
assay) from cell lysates were incubated with a molar excess
of an iron-responsive elements probe and in the absence or
presence of β-mercaptoethanol 2% and sequentially treat-
ed with RNase T1 and heparin. After separation on non-
denaturing polyacrylamide gels (6%), RNA-protein com-
plexes were visualized by autoradiography. IRP/IRE bind-
ing activity was measured by means of densitometric scan-
ning of the autoradiograph, making sure that all signals
were in the linear range.
Western blot analysis 
Macrophage lysates were prepared in Tris 10 mM at pH
8.0, NaCl 150 mM, Nonidet P40 1%, sodium dodecylsul-
fate (SDS) 0.1%, EDTA 10 mM and protease inhibitors
(Sigma). Lysates were centrifuged at 16,000 x g for 5 min at
4 °C.  For western blot analyses, equal amounts of protein
were resolved by SDS polyacrylamide gel electrophoresis
(PAGE) and transferred onto Immobilon-P (Millipore). After
Ponceau S staining, membranes were saturated in Tris-HCl
20 mM, pH 7.6, NaCl 150 mM (Tris-buffered saline) con-
taining non-fat milk 5% and Tween 20 0.1%. Antigens
were detected using either rabbit polyclonal anti-FtH, kind-
ly provided by S. Levi (Milan),11 or mouse monoclonal anti-
TfR1 (Invitrogen), rabbit polyclonal anti-HO-1 (Santa Cruz
Biotechnology, H-105), rabbit anti-mouse ferroportin IgG
(Alpha Diagnostic International, MTP11-A), or mouse
monoclonal anti- β-actin (Sigma, clone AC15) antibodies.
Primary antibodies were revealed with horseradish peroxi-
dase-conjugated secondary antibodies (Amersham
Biosciences, Milan, Italy) and a chemiluminescence kit
(ECL, Amersham Biosciences). 
Analysis of 55Fe-labeled ferritin 
Macrophages were incubated overnight with ascorbic
acid in the presence of [55Fe] ferric iron citrate (10 μCi/mL,
2.5 μM iron) or with 2.5 μM transferrin bound 55Fe. In
selected experiments, the overall concentration of FAC was
brought to 150 μM by addition of unlabeled FAC. Ferric
iron citrate was prepared by mixing 55FeCl3 (PerkinElmer
Life Sciences) with citric acid (1:2 molar ratio). Cells were
then washed three times with phosphate-buffered saline
and either lysed in Tris 20 mM, pH=7.5 containing 0.5%
Triton X100 or chased for an additional 24 h in complete
medium in the presence of bathophenantrolin (100 μM)
before lysis. Lysates were centrifuged and aliquots of the
supernatant used for protein determination or mixed with
Ultima Gold (Packard Instrument Co.) to measure cellular
55Fe by liquid scintillation. To evaluate 55Fe incorporation
into ferritin (Ft), equal amounts of proteins from super-
natants were analyzed by non-denaturing PAGE and visu-
alized by autoradiography.12 In selected experiments, to
detect FtH, equal amount of proteins were separated on
7.5% native polyacrylamide gels and transferred onto
Immobilon-P membrane. The membrane was probed with
a rabbit polyclonal antibody raised against rm-FtH subunit,
and Ft detected by chemiluminescence as before.  
Quantification of the labile iron pool  
The labile iron pool was measured by loading cells with
the iron-sensitive probe Calcein-AM (Molecular Probes) as
previously described.13 Briefly, macrophages were incubat-
ed in 48-well plates with αMEM supplemented with 1
mg/mL bovine serum albumin and 0.25 μM Calcein-AM at
37°C for 15 min. After two cycle washes, cells were main-
tained in HBSS supplemented with 10 mM glucose and flu-
orescence was revealed during the following 20 min using
the Victor3 Multilabel Counter (Wallac, Perkin Elmer) at
485 nm (excitation) and 535 nm (emission). The iron chela-
tor deferiprone, kindly provided by Apopharma Inc.
(Toronto, ON, Canada) was then added to reach 300 μM
final concentration and fluorescence was re-determined.
After 10 min, fluorescence increases induced by iron chela-
tor were normalized on protein content, assessed by the
BCA assay, and considered as labile iron pool (LIP) values.
Quantification of the total iron pool 
Iron was determined by inductively coupled plasma
mass spectrometry (ICP-MS) using a Perkin Elmer ELAN
DRC II instrument (Perkin Elmer Sciex, Woodbridge, ON,
Canada) and total quant technique with external calibra-
tion. For each sample, two runs were performed (two repli-
cates each), with a dynamic reaction cell. The accuracy of
the method was determined in natural water and bovine
liver standard reference materials (NIST 1640 and
MS1577b, respectively, National Institute of Standard and
Technology, Gaithersburg, MD, USA) and resulted around
87.5%. The coefficients of variation ranged from 6% to 8%
among series and from 6% to 12% between series. The
instrument was calibrated using standard solution at a con-
centration of 10 µg/L (Multielement ICP-MS Calibration
Standard 3, Matrix per Volume: 5% HNO3 per 100 mL,
Perkin Elmer Plus). The limits of detection were determined
on the basis of three standard deviations of the background
signal, and a value of 0.005  was obtained.
Antigen presentation assay 
Antigen presentation was carried out as described else-
where,14 with minor modifications. Briefly, macrophages
were incubated overnight in complete medium in the pres-
ence or in the absence of DFO (150 μM). Macrophages
were then harvested, washed and incubated for 90 min at
37°C in 5% CO2 in the presence or absence of ovalbumin
(1 mg/mL, Sigma-Aldrich) in RPMI 1640 medium
(Euroclone) containing 10% fetal bovine serum (Lonza) and
β-mercaptoethanol (50 μM, GIBCO, Invitrogen). Cell via-
bility was routinely verified and was consistently greater
than 98%. Class II-restricted BO97.10.2 T hybridoma cells,
specific for the epitope between residues 327–339 of oval-
bumin, were added to be stimulated overnight (using a 4:1
macrophages/T cells ratio). IL-2 secretion was assessed by
ELISA (Duoset Muose IL2, R&D Systems). 
Statistics 
Data are expressed as means±standard error mean (SEM)
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from at least three independent experiments. The statistical
analysis was performed using Student's t-test for unpaired
data. P values less than 0.05 were considered statistically
significant.
Results
Macrophage polarization shapes the expression of genes
involved in iron metabolism
We relied on established protocols7 to polarize M-CSF-
elicited macrophages into M1 and M2 cells. As expected,15
IFNγ-treated macrophages displayed a typical M1 gene sig-
nature and IL4-treated macrophages had a typical M2 gene
signature, characterized by specific patterns of cytokines,
chemokines and receptors;16 Table 1). Macrophage polariza-
tion was confirmed by flow cytometry and by evaluating
the concentration of selected soluble molecules in the cul-
ture supernatant: M1 macrophages expressed high levels of
molecules involved in T-cell activation and co-stimulation,
such as MHC class I (H-2Kb) and class II (I-Ab) and CD86
and secreted pro-inflammatory molecules such as TNFα
and IL6 (Online Supplementary Figure S1 and Table 2). M2
cells expressed high levels of scavenger receptors, such as
the CD163 hemoglobin/haptoglobin receptor and secreted
molecules involved in the regulation of the immune system
such as TNFα soluble receptors, CXCL12, IL4, and IL13
(Online Supplementary Figure S1 and Table 2).
Polarization of macrophages skews the expression pro-
file of genes involved in iron metabolism. In particular M1
macrophages showed high expression of the Ft heavy
chain 1 (Fth1), of the natural resistance-associated
macrophage protein 1 (Nramp1), involved in defense
against intracellular pathogens, of β2-microglobulin (b2m),
HIF1a (Hif-1a) and superoxide dismutase 2 (SOD2) and low
expression of TfR1 (Tfr1) and Steap 3 (Steap3), which are
involved in iron uptake. M1 macrophages expressed ceru-
loplasmin (Cp), had minimal expression of hepcidin
(Hamp1) and low HO-1 (Hmox1) expression. On the other
hand, M2 macrophages were characterized by lower
expression of Fth1 and higher expression of Tfr1, DMT1
(Slc11A1), Irp1 and Irp2, Tf, Hfe, ferroportin 1 (Scl40a1) and
Hmox1 as compared to M1. They expressed higher levels of
aminolevulinic acid synthase 1 (Alas1) and frataxin (Fxn),
which are involved in mitochondrial iron utilization. The
expression of ferritin light chain (Ftl) was similar in both M1
and M2 cells (Table 1). 
Macrophage polarization shapes the RNA binding 
activity of iron-regulatory proteins 1 and 2 
Because of the opposite behavior of FtH and TfR1 in M1
and M2 macrophages we verified the IRP-IRE binding
activity in polarized macrophages. The results of band shift
assays (Figure 1) indicated that RNA binding activity of
IRP1 was significantly lower in M1 macrophages than in
M2. IRP2 activity was very low in M1 macrophages. This
is relevant in view of the greater importance in iron regula-
tion of IRP2 compared to IRP1 in cultured mammalians
cells.17
Next we explored whether iron regulation of IRP1 and
IRP2 is maintained in both macrophage populations (Figure
1). In the presence of an excess of heme iron (100 μM) IRP1
and IRP2 binding activity was nearly abolished in both M1
and M2, as expected. Iron deficiency induced by treatment
with DFO strongly enhanced the IRP1 activity in both
macrophage populations. The effect of iron chelation on
IRP2 activity was more pronounced in M2 macrophages.
As expected, the IRP1 activity increased in both M1 and
M2 macrophages in the presence of β-mercaptoethanol
(Online Supplementary Figure S2). 
We then analyzed by western blotting (Figure 2A) and
qPCR (Figure 2B) molecules involved in cellular iron home-
ostasis. In agreement with their low IRP activity M1
Iron handling by polarized macrophages
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Table 2. Concentrations of soluble molecules in the supernatants of
polarized M1 and M2 macrophages assessed by ELISA.
                                                  M1                                        M2
TNFα                                        716.76±294.39                                       n.d.
sTNFR-I                                     708.11±60.63                               502.83±64.22
sTNFR-II                                   503.67±82.26                             1147.94±110.78
CXCL12                                         0.42±0.42                                     18.33±7.38
IL4                                                14.61±12.7                                  1494.57±57.7
IL10                                           418.77±189.51                               42.79±13.16
IL6                                              109.25±16.76                                76.26±10.64
IL13                                                    n.d.                                        521.79±83.43
Values are given in pg/mL; n.d.: not detectable; sTNFR-I: soluble TNF receptor-I;
sTNFR-II: soluble TNFα receptor-II.
Table 1. Expression profile of genes differentially expressed in M1 and
M2 polarized macrophages. 
Only those genes whose expression varied between the two macrophage populations
are shown. Values refer to the Affymetrix® GeneChip® Command Console® (AGCC)
Software signal and represent the mean of the results of three independent experiments.
Black cells indicate transcripts with an “absent” call; signals for transcripts with a pres-
ent call are shown in gradient-colored cells from blue (low abundance) to dark red
(very highly abundant transcript). Genes are ranked according to their fold difference
between M1 and M2. Positive values refer to the ratio between M1 and M2, negative val-
ues to the ratio between M2 and M1.
macrophages expressed high levels of FtH (both at RNA
and protein levels) and low levels of TfR1. However, Fpn
protein (expected to be regulated as FtH) was low, since
transcriptionally down-regulated, and HO-1 was virtually
absent. M2 macrophages expressed low levels of FtH and
high levels of TfR1, consistent with their high IRP-binding
activities; compared to M1 macrophages, they expressed
higher amounts of Fpn (Figure 2A). These expression pat-
terns were unaffected by antibodies blocking IL4 and IFNγ,
ruling out an effect on the regulation of iron-related genes
of residual recombinant cytokines used to polarize
macrophage precursors (data not shown). 
Macrophage polarization influences the response to iron
overload and depletion
To verify the response of M1 and M2 macrophages to
cellular iron variations, we analyzed the expression of FtH,
TfR1, HO-1 and Fpn in conditions of iron overload and
depletion. Figure 2A shows that macrophage polarization
shaped the response to iron availability in the microenvi-
ronment. Non-heme iron (FAC) enhanced FtH expression
both at the translational and the transcriptional levels and,
although to a lesser extent, Fpn in both M1 and M2
macrophages. FAC also enhanced HO-1 mRNA (from
0.05±0.003 to 0.2±0.03, P=0.001, in M1 cells and from
G. Corna et al.
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Figure 1. RNA binding activity of
IRP1 and IRP2. (A) Cytoplasmic
extracts of M1 and M2
macrophages, treated or not with
hemin (100 μM) or DFO (150
μM), were incubated with an
excess of a 32P-labeled iron
responsive element probe. RNA-
protein complexes were resolved
on non-denaturing polyacry-
lamide gels and revealed by
autoradiography. The result
shown is representative of three
independent experiments. (B)
Radioactivity associated with
RNA protein complexes was
quantified and plotted (arbitrary
units, a.u., y axis). * P<0.05; **
P<0.001, significantly different
from control.
Figure 2. Expression of proteins
involved in iron metabolism in
M1 and M2 macrophages. (A)
Western blot analysis of the
expression of FtH, TfR1, HO-1 and
Fpn in M1 and M2 macrophages,
either untreated or incubated
over night in the presence of FAC
(150 μM), hemin (100 μM) and
DFO (150 μM). Results shown are
representative of three independ-
ent experiments. (B) qPCR analy-
sis of FtH, TfR1, HO-1 and Fpn in
M1 and M2 macrophages, either
untreated or incubated overnight
in the presence of FAC (150 μM),
hemin (100 μM) or DFO (150
μM). 
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0.1±0.004 to 0.22±0.02, P=0.0009, in M2 cells) and protein
expression in M2 macrophages. As expected, heme-iron
strongly induced both mRNA and protein HO-1 levels,
especially in M2. FtH was up-regulated in M1, but surpris-
ingly not in M2 (Figure 2A), whereas TfR1 expression was
significantly down-regulated in both macrophage popula-
tions (Figure 2 and Online Supplementary Figure S3). Heme-
iron strongly induced Fpn mRNA in both M1 and M2
macrophages, although the effect was less evident at the
protein level. Selective qPCR failed to detect the non-IRE
Fpn isoform (data not shown), suggesting that both
macrophage populations expressed only the IRE form.18
DFO treatment further enhanced TfR1 expression in M2
macrophages, but not in M1 ones (Figure 2A,B; Online
Supplementary Figure S3) and reduced Fpn in both cell types.
Moreover, iron chelation failed to suppress FtH expression
in M1 macrophages.  These data demonstrate that M1
macrophages have an iron storage phenotype, which is not
influenced by the presence or absence of iron in the envi-
ronment and that M2 macrophages have a phenotype rem-
iniscent of iron deficiency. 
Polarization influences the size of the labile iron pool
and the ability of macrophages to internalize and release
iron
Under basal conditions, the total amount of iron of M1
and M2 macrophages was similar (0.026 and 0.028 ng/106
cells, respectively). To investigate the size of the labile iron
pool (LIP) we used a metallo-sensor fluorescent probe (cal-
cein). M1 macrophages did not have a detectable LIP,
which, in contrast, was revealed in labeled M2
macrophages after addition of the iron chelator deferi prone
(Figure 3A). The difference was highly statistically signifi-
cant (Figure 3B). To investigate the ability of M1 and M2
cells to handle iron, we challenged polarized macrophages
with radioactive 55Fe (2.5 μM FAC) and verified their ability
to internalize, bind to Ft and release the metal during a 24
h chase period. M1 cells (Figure 4) failed to internalize 55Fe
efficiently. In contrast M2 cells effectively took up the
metal and displayed a large amount of cell-associated and
Ft-bound 55Fe (Figure 4A,B). After a 24 h chase, cell-associ-
ated and Ft-bound 55Fe decreased only in M2 cells (Figure
4A,B), indicating active release of iron. Similar results were
obtained when M1 and M2 macrophages were challenged
with radioactive Tf-bound iron (Figure 4C,D). To investi-
gate whether the amount of iron in the environment influ-
ences the efficiency of the response, we verified the ability
Iron handling by polarized macrophages
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Figure 3. Labile iron pool in M1
and M2 macrophages. (A)
Representative graph illustrat-
ing calcein fluorescence modu-
lation in M1 and M2 macro -
phages before and after
deferiprone addition. Data are
presented as averages of four
independent determinations for
each experimental point. (B)
Quantification of LIP. Data are
presented as averages of three
independent experiments, each
done as in (A). Error bars indi-
cate standard deviations. DPN:
deferiprone. * P<1.5x10-5.
Figure 4. Incorporation and release of 55Fe by M1 and M2
macrophages. M1 and M2 macrophages were incubated overnight
with [55Fe] ferric iron citrate (2.5 μM iron) in the presence of ascorbic
acid (A) and (B) or with 2.5 μM transferrin bound 55Fe (C and D), or
with [55Fe] ferric iron citrate in the presence of ascorbic acid (150 μM
iron, E), washed and lysed either immediately or after a 24 h chase.
(A, C and E) Cell-associated radioactivity (cpm/mg of protein extract,
y axis) was evaluated. Results represent the mean ± SD of quadru-
plicate samples. **P<0.01, significantly different from control. (B
and D) Cell extracts were obtained at the times indicated and were
resolved on a native polyacrylamide gel. Radioactive iron incorpora-
tion into Ft was evaluated by autoradiography.
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of polarized macrophages to handle a 50-fold higher con-
centration of iron (150 μM final concentration: 55Fe-FAC 2.5
μM-unlabeled iron 147.5 μM), i.e. in conditions in which
we observed Fpn induction in M1 macrophages (Figure 2).
As shown in Figure 4E, in these conditions M1 internalized
iron, although less effectively than M2 cells did and both
M1 and M2 macrophages released a substantial fraction of
the internalized iron upon a 24 h chase: M2 were again
more effective than M1 cells at releasing 55Fe. These data
suggest that M1 macrophages are able to take up and
release iron when challenged with high concentrations of
the metal, and confirm the ability of M2 macrophages to
recycle iron.
M2 macrophages depend on iron for T-cell activation
We verified the ability of M1 and M2 cells to present
epitopes derived from nominal antigens to T lympho-
cytes: T lymphocyte activation was assessed by measur-
ing IL2 secretion. Under basal conditions, M1 and M2
macrophages were almost equally effective at activating
antigen-specific T cells. However, in condition of iron
deficiency, T-cell activation by M2 cells abates (Figure 5)
and the expression of molecules involved in antigen pres-
entation, such as MHC class II (I-Ab), or in T-cell co-stim-
ulation, such as CD86, was consensually reduced. In con-
trast, T-cell activation by M1 cells was maintained in con-
ditions of iron chelation (Figure 5).
Discussion
Macrophages fulfill key functions in immunity. In partic-
ular, they are vital for the response to invading pathogens
and for the regeneration of injured tissues. Specialized dif-
ferentiation programs triggered in resting macrophages by
environmental stimuli have been identified and are referred
to as “classical” or “alternative” activation. 
Classically activated/M1 macrophages have inflammato-
ry functions: they produce effector molecules and inflam-
matory cytokines, participate as inducer and effector cells
in polarized Th1 responses and mediate resistance against
intracellular microbes and tumors. Alternatively activat-
ed/M2 macrophages participate in polarized Th2 reactions,
promote killing and encapsulation of parasites and are pres-
ent in established tumors where they promote progression.
Moreover, they are involved in wound healing and have
immunoregulatory functions.1 Cytokines, IFNγ and IL4, in
particular, drive macrophage polarization. The effect of the
cytokines is not restricted to single genes. They involve
specific well-defined gene signatures, which allow polar-
ized macrophages to exert their biological functions.16,19
The limited ability of M1 macrophages to recycle iron is
possibly involved in the ability of these cells to control bac-
terial pathogenicity. Limited intracellular iron availability
has been clearly demonstrated to impair intracellular
pathogen growth thus facilitating the microbicidal function
of macrophages.2,20,21 It is tempting to speculate that this
function is preferentially associated with macrophages
polarized towards an M1 phenotype, which are character-
ized by a restricted LIP. Further studies are warranted to
address this issue. 
M1 macrophages express high levels of FtH and low lev-
els of Fpn, CD163, TfR1 and HO-1. The culture conditions
we used were not suitable for the detection of the transient
autocrine synthesis of hepcidin that has been identified in
stimulated human monocytes;22 particularly so since to
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Figure 5. Effects of iron availability on
antigen presentation by M1 and M2
cells. (A) M1 (open bars) and M2 (filled
bars) macrophages were used to acti-
vate MHC class II-restricted T hybrido-
ma cells specific for the nominal anti-
gen ovalbumin (OVA). When indicated,
the iron chelator DFO was added. T-cell
activation was assessed by IL2 secre-
tion (pg/mL, y axis, see Design and
Methods). T-cell activation, as expect-
ed, was detectable only when antigen-
presenting cells (M1/M2), T cells and
the antigen (OVA) were present. DFO
did not influence T-cell activation by
M1 macrophages, but significantly
inhibited T-cell activation by M2
macrophages. (B): M1 and M2
macrophages, cultured in the pres-
ence or absence of DFO, were ana-
lyzed by flow cytometry after staining
with antibodies directed against MHC
class II molecules (I-Ab) or against the
CD86 co-stimulatory molecule. Filled
histograms represent the binding of
specific antibodies, whereas open his-
tograms represent the fluorescence
background obtained in the presence
of isotype-matched control antibodies.
Numbers indicate the relative fluores-
cence intensity (RFI) values, calculated
dividing the mean fluorescence inten-
sity obtained in the experimental sam-
ple by the one obtained with the rele-
vant control. The results shown are
representative of three independent
experiments. ** P<0.01, significantly
different from control.
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drive M1 polarization we used recombinant IFNγ alone in
the absence of microbial co-stimuli. The basal expression of
Fpn was negligible. M1 macrophages, which directly deal
with microbes at sites of infection, down-regulate Fpn, thus
limiting release of iron which could favor invading
pathogens. On the other hand, by up-regulating FtH
expression and limiting the size of the LIP, M1 cells possibly
protect themselves against oxidative damage23 and further
limit the availability of the molecule to internalized
microbes.
Macrophages that phagocytose senescent red blood cells
represent the major cellular system responsible for supply-
ing iron required for erythropoiesis.6,24-26 Ingested heme is
degraded within the phagolysosomes by the enzyme HO-
127,28 and iron is released to the extracellular environment.
Iron that is not released is mostly incorporated into Ft, the
central protein for iron storage.29,30 Therefore, macrophages
in charge of recycling iron are expected to have a relatively
high ability to internalize senescent cells, to endocytose
transferrin-bound iron via TfR, and to release but not to
store iron. M2 macrophages satisfy these requirements:
they are professional scavengers of senescent and apoptotic
cells.31,32 Furthermore we found that they express high lev-
els of membrane molecules involved in iron internalization,
such as TfR1 and the CD163 hemoglobin/haptoglobin
receptor, and low levels of FtH. 
Accordingly, they effectively internalize and release
radioactive iron. The expression of Fpn, which is further
enhanced in the presence of heme and non-heme iron, is
critical for the transport of the metal since Fpn is the sole
mammalian iron exporter so far characterized. Its over-
expression causes, for example, enhanced release of iron
derived from the processing of phagocytosed erythro-
cytes.26 Hemin has a role in the control of Fpn transcrip-
tion. Heme binds Fpn promoter33 and the heme protopor-
phyrin ring effectively increases Fpn transcription in
immortalized murine macrophages.34 FtH and Fpn protein
levels are under the control of the iron-dependent IRP-IRE
regulation. Effective Fpn translation due to IRP–IRE inter-
actions is possibly limited due to the relatively low
amount of iron released from heme, as reflected by the
poor induction of FtH. Accordingly Fpn protein levels
were not substantially modified in hemin-treated cells as
compared to untreated cells. 
A reduction of circulating iron also stimulates T-cell-
dependent anti-microbial acquired immunity, favoring the
shift towards Th1 responses.35-38 M1 macrophages differen-
tiate under the control of cytokines produced by Th1 cells,
and in turn sustain establishment and maintenance of Th1
responses.3,39 Here we observed that M1 cells maintained
the ability to present antigens to memory T cells even after
iron depletion: this feature possibly allows them to keep
activating pathogen-specific T cells in conditions scarcely
permissive for microbe spreading. In contrast, the ability of
M2 macrophages to activate T cells abated in the absence
of iron. Interestingly, low environmental iron was recently
reported to result in defective production of cytokines by
activated macrophages.40 Further studies are warranted to
better characterize the effect of polarized iron handling by
macrophages on acquired immune functions.
M2 cells play a pivotal role in sustaining angiogenesis,
wound repair and tumor growth.41,42 These functions are
associated with their ability to provide nutrients, including
iron, to the healing tissues. Interestingly, M2 macrophages
are necessary for the regeneration of acutely injured skele-
tal muscles,43 i.e. a condition in which large amounts of the
metal are essential to build new, functional myofibers. 
Our results indicate that M1 and M2 macrophages main-
tained iron-IRP regulation, although their iron sensing was
reset according to their role. M1 had increased FtH and low
TfR1, but to escape iron control they suppressed Fpn tran-
scription. M1 were still sensitive to increased iron, but, in
keeping with their storage phenotype, they were almost
insensitive to DFO. 
In contrast M2 had a clear iron-deficient phenotype.
They actively took up iron that they were unable to store.
Even in the presence of high iron concentrations they did
not suppress TfR1 and did not activate FtH. Still M2
macrophages could respond to DFO further increasing
TfR1 expression. 
Via the HIF1α pathway hypoxia elicits a coordinated
response for controlling iron metabolism and oxygen trans-
port, mediated via hepcidin/ferroportin.44 Our study sug-
gests a differential expression of the transcription factor in
the M1 and M2 populations, and modulations at this level
are possibly involved in macrophage polarization.45
Confirmation of this possibility will require further experi-
ments.
Our results agree well with those recently published by
Recalcati et al. using human monocyte-derived macro -
phages.46 The conservation of the pathway between mouse
and human clearly indicates that a dichotomy in iron han-
dling represents a general feature of the functional polariza-
tion of macrophages. Resting macrophages appear to have
the potential to differentiate towards subpopulations of
cells with distinct patterns of iron handling (Figure 6),
which may be instrumental for their homeostatic roles in
conditions as diverse as the inflammatory response to
invading microbes or the repair of injured tissues.
Moreover, our results reveal an instructive role of environ-
mental cytokines in determining iron homeostasis. 
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